Lv4
464 积分 2023-12-22 加入
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
29天前
已完结
NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
1个月前
已完结
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk
2个月前
已完结
Structure-based design and disulfide stapling of interfacial cyclic peptidic inhibitors from thymic stromal lymphopoietin (TSLP) receptor to competitively target TSLP
3个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
6个月前
已完结
Virtual Screening Combined with Phase Transition-FRET for Discovery of Small-Molecule FcRn Antagonists
7个月前
已完结
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
7个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
7个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
7个月前
已完结
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
8个月前
已完结
皖公网安备34019202002308
